Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Lett Appl Microbiol ; 45(4): 426-31, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17897387

RESUMO

AIM: Rapid characterization of variable region (VR)1 variants of the porA gene among invasive strains is crucial for outbreak management and epidemiology studies. Recent sequence analysis studies in Brazil showed that the VR1 P1.7 and P1.19 variants are highly prevalent, accounting for 68%, of the total number of VR1 variants characterized. The aim of this work is to develop a rapid polymerase chain reaction (PCR)-based method for genosubtyping Neisseria meningitidis by detection of porA variable regions P1.7 and P1.19. METHODS AND RESULTS: PCR primers for the detection of porA VR1 P1.7 and P1.19 were designed and tested using 198 clinical N. meningitidis isolates that had been previously evaluated by porA sequencing. All 50 strains with VR1 P1.7 and all 65 strains with VR1 P1.19 were positively identified by the respective VR-specific PCR and no false-positive reactions occurred. CONCLUSIONS: VR-specific PCR amplification accurately identified VR P1.7 and P1.19 strains. SIGNIFICANCE AND IMPACT OF THE STUDY: To overcome the disadvantages of serosubtyping and sequencing for typing the porA VR1 segment of N. meningitidis, we developed a PCR-based method to rapidly and accurately detect VR1 P1.7 and P1.19 variants. This approach is highly specific and sensitive; moreover it may allow for genotype determination of culture-negative samples.


Assuntos
Infecções Meningocócicas/microbiologia , Neisseria meningitidis/isolamento & purificação , Reação em Cadeia da Polimerase , Porinas/isolamento & purificação , Técnicas de Tipagem Bacteriana , Brasil , Primers do DNA , Humanos , Infecções Meningocócicas/diagnóstico , Neisseria meningitidis/genética , Neisseria meningitidis/imunologia , Porinas/genética , Porinas/imunologia
2.
Braz J Med Biol Res ; 38(5): 777-81, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15917960

RESUMO

Few vaccines in history have induced such a dramatic decline in incidence over such a short period of time as the Haemophilus influenzae type b (Hib) conjugate. This vaccine was introduced in 1988 in the United States, but only in 1999 was Hib immunization introduced by the Brazilian Ministry of Health as part of the routine infant National Immunization Program. The authors analyzed 229 H. influenzae (Hi) isolates from Public Health Laboratories in three Brazilian states: Pernambuco (Northeast, N = 54), Santa Catarina (South, N = 19), and Rio de Janeiro (Southeast, N = 156). The isolates were collected from Brazilian children 0-10 years of age with meningitis and other infections from 1990 to 2003 and were part of the research collection of the National Institute of Quality Control in Health, FIOCRUZ. Bacterial strains were characterized by serotyping and biotyping. During the pre-vaccination period the prevalence infection due to Hib was of 165 isolates and only 2 non-b Hi among all the notified meningitis infections caused by Hi. Our results showed a significant decrease in the prevalence of Hib meningitis from 165 to 33 isolates after 1999. However, during the post-vaccination period of 2001-2003 we observed an increase in the number of non-b Hi isolates: only 2 non-b strains isolated from 1990 to 1999 and 29 from 1999 to 2003. Based on the present data, the authors emphasize the need for more sensitive epidemiological and bacteriological studies aiming the improvement of the available Hib vaccine, in order to protect the susceptible population to infections due to other serological types of Hi and the reevaluation of immunization schedules used by the National Immunization Program.


Assuntos
Vacinas Anti-Haemophilus/administração & dosagem , Haemophilus influenzae tipo b/classificação , Meningite por Haemophilus/virologia , Polissacarídeos Bacterianos/administração & dosagem , Vacinação , Cápsulas Bacterianas , Brasil/epidemiologia , Criança , Pré-Escolar , Genótipo , Haemophilus influenzae tipo b/genética , Humanos , Programas de Imunização , Lactente , Recém-Nascido , Meningite por Haemophilus/epidemiologia , Meningite por Haemophilus/prevenção & controle , Programas Nacionais de Saúde , Prevalência , Sorotipagem , Vacinas Conjugadas/administração & dosagem
3.
Braz. j. med. biol. res ; 38(5): 777-781, May 2005. tab
Artigo em Inglês | LILACS | ID: lil-400961

RESUMO

Few vaccines in history have induced such a dramatic decline in incidence over such a short period of time as the Haemophilus influenzae type b (Hib) conjugate. This vaccine was introduced in 1988 in the United States, but only in 1999 was Hib immunization introduced by the Brazilian Ministry of Health as part of the routine infant National Immunization Program. The authors analyzed 229 H. influenzae (Hi) isolates from Public Health Laboratories in three Brazilian states: Pernambuco (Northeast, N = 54), Santa Catarina (South, N = 19), and Rio de Janeiro (Southeast, N = 156). The isolates were collected from Brazilian children 0-10 years of age with meningitis and other infections from 1990 to 2003 and were part of the research collection of the National Institute of Quality Control in Health, FIOCRUZ. Bacterial strains were characterized by serotyping and biotyping. During the pre-vaccination period the prevalence infection due to Hib was of 165 isolates and only 2 non-b Hi among all the notified meningitis infections caused by Hi. Our results showed a significant decrease in the prevalence of Hib meningitis from 165 to 33 isolates after 1999. However, during the post-vaccination period of 2001-2003 we observed an increase in the number of non-b Hi isolates: only 2 non-b strains isolated from 1990 to 1999 and 29 from 1999 to 2003. Based on the present data, the authors emphasize the need for more sensitive epidemiological and bacteriological studies aiming the improvement of the available Hib vaccine, in order to protect the susceptible population to infections due to other serological types of Hi and the reevaluation of immunization schedules used by the National Immunization Program.


Assuntos
Recém-Nascido , Lactente , Pré-Escolar , Criança , Humanos , Vacinas Anti-Haemophilus/administração & dosagem , Haemophilus influenzae tipo b/genética , Meningite por Haemophilus/prevenção & controle , Polissacarídeos Bacterianos/administração & dosagem , Vacinação , Vacinas Conjugadas/administração & dosagem , Brasil/epidemiologia , Genótipo , Haemophilus influenzae tipo b/classificação , Programas de Imunização , Meningite por Haemophilus/epidemiologia , Meningite por Haemophilus/virologia , Programas Nacionais de Saúde , Prevalência , Sorotipagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA